SG Americas Securities’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

SG Americas Securities’s Portfolio SYRS Stock Details SYRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,201	Closed	-$39K	–	3540
2021 Q4	$39K	Sell	1,201 -1,909	-61%	-$77.3K	﹤0.01%	3216
2021 Q3	$139K	Buy	+3,110	New	+$152K	﹤0.01%	3483
2021 Q2	–	Sell	-1,651	Closed	-$123K	–	3308
2021 Q1	$123K	Buy	+1,651	New	+$172K	﹤0.01%	2971
2020 Q3	–	Sell	-2,262	Closed	-$241K	–	3570
2020 Q2	$241K	Buy	2,262 +875	+63%	+$78.5K	﹤0.01%	2705
2020 Q1	$82K	Buy	+1,387	New	+$94.1K	﹤0.01%	3072

Other funds holding SYRS

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

ABG

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

SG Americas Securities's SYRS Position: Q1 2022 in Review

SG Americas Securities sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q1 2022, closing a stake of 1,201 shares — an estimated $39K sold.

SG Americas Securities first reported a position in SYRS in Q1 2020 and held it in 5 quarters. The position peaked at $241K in Q2 2020. 94 funds tracked by Wall St. Rank hold SYRS as of Q1 2022.

SG Americas Securities reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
SG Americas Securities sold 1,201 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $39K.
SG Americas Securities first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 5 quarters.
SG Americas Securities's Syros Pharmaceuticals, Inc. Common Stock position peaked at $241K in Q2 2020.
94 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on SG Americas Securities's 13F filing for Q1 2022, filed 29 Apr 2022.